Why would you trust him and his source? His source is likely using him to spread false expectations. And this dude is falling for it! ;)
LP has told shareholders indirectly that they expect to be busy addressing MHRA questions and that’s why they are not attending ASCO. That basically means don’t expect UK approval in Q2.
Have some dry powder ready to average down in June-July at all time lows!